Jennifer Butler

Jennifer Butler is an accomplished executive with extensive experience in the biopharmaceutical industry. Currently serving as an Executive in Residence with BioHealth Innovation, Inc. and Montgomery County since November 2022, Jennifer provides business assistance to local biotech entrepreneurs. Previously, as a Strategic Advisor at Buvero BioAdvisors, Jennifer delivered corporate and commercial solutions for biopharma companies. Jennifer has held key leadership positions, including Executive Vice President at Innate Pharma and Chief Business Officer at Tessa Therapeutics Ltd. Notable experience at AstraZeneca involved leading global commercial strategies for immuno-oncology products, while earlier roles at MedImmune, Insight Strategy Advisors, Merrill Lynch, and Thomson Financial further solidified a strong background in commercial operations and market research. Jennifer holds a B.A. in Biological Basis of Behavior from the University of Pennsylvania.